Faeth Therapeutics (FTH) Return on Equity [ROE] (2021 - 2026)
Faeth Therapeutics' Return on Equity [ROE] came in at -1097.03% for Q2 2026, down 1006.57 percentage points from -90.46% a year earlier.
Powered by 
Analysis
Faeth Therapeutics (FTH) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Faeth Therapeutics' Return on Equity [ROE] was -74.00%, down 15.60 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last three years, though with a four-year change of +8.94 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -58.39% in FY2024 (-18.48 pp), -39.91% in FY2023 (-1.00 pp), -38.91% in FY2022 (+44.03 pp) and -82.94% in FY2021.
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 11.06 percentage points), and the weakest in Q2 2026 (a drop of 1006.57 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Faeth Therapeutics | 115.80 Mn | -319.66 Mn | - | -1,097.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,097.03% |
| Dec 31, 2025 | -101.47% |
| Sep 30, 2025 | -95.93% |
| Jun 30, 2025 | -90.46% |
| Mar 31, 2025 | -82.59% |
| Dec 31, 2024 | -71.65% |
| Sep 30, 2024 | -60.70% |
| Jun 30, 2024 | -53.08% |
| Mar 31, 2024 | -51.05% |
| Dec 31, 2023 | -49.43% |
| Sep 30, 2023 | -51.22% |
| Jun 30, 2023 | -51.72% |
| Mar 31, 2023 | -46.69% |
| Dec 31, 2022 | -44.73% |
| Sep 30, 2022 | -38.16% |
| Jun 30, 2022 | -32.61% |
| Mar 31, 2022 | -29.66% |
| Dec 31, 2021 | -24.76% |
| Sep 30, 2021 | -20.79% |
| Jun 30, 2021 | -16.87% |
API Access
Faeth Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "FTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();